Vyro Bio

www.vyrobio.com

Vyro Bio is pioneering a novel class of tumor-directed oncolytic immunotherapies for malignant central nervous system (CNS) tumors, both pediatric and adult. Our focus is to revolutionize the treatment of these tumors through the development of oncolytic viruses (OVs) based on the properties of the Zika virus.   A Vyro é pioneira em uma nova classe de imunoterapias direcionadas a tumores malignos do sistema nervoso central (SNC), tanto pediátricos quanto adultos. O foco é a revolução do tratamento desses tumores através do desenvolvimento de vírus oncolíticos baseados nas propriedades do Zika vírus.

Read more

Reach decision makers at Vyro Bio

Lusha Magic

Free credit every month!

Vyro Bio is pioneering a novel class of tumor-directed oncolytic immunotherapies for malignant central nervous system (CNS) tumors, both pediatric and adult. Our focus is to revolutionize the treatment of these tumors through the development of oncolytic viruses (OVs) based on the properties of the Zika virus.   A Vyro é pioneira em uma nova classe de imunoterapias direcionadas a tumores malignos do sistema nervoso central (SNC), tanto pediátricos quanto adultos. O foco é a revolução do tratamento desses tumores através do desenvolvimento de vírus oncolíticos baseados nas propriedades do Zika vírus.

Read more
icon

Country

icon

City (Headquarters)

São Paulo

icon

Employees

1-10

icon

Founded

2021

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Scientific Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Board Member

    Email ****** @****.com
    Phone (***) ****-****
  • Member of the Scientific Advisory Board

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(6)

Reach decision makers at Vyro Bio

Free credits every month!

My account

Sign up now to uncover all the contact details